Shree Renuka Sugars Ltd

Sh.Renuka Sugar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shree Renuka Sugars Ltd

₹ 27.8 -4.63%
10 Mar - close price
renukasugars.com BSE: 532670 NSE: RENUKA
About

Incorporated in 1995, Shree Renuka Sugars Ltd does manufacturing and refining of sugar, ethyl alcohol, ethanol, generation and sale of power[1]

Key Points

Business Divisions

Website BSE NSE
  • Market Cap ₹ 5,913 Cr.
  • Current Price ₹ 27.8
  • High / Low ₹ 56.5 / 25.6
  • Stock P/E
  • Book Value ₹ -1.20
  • Dividend Yield 0.00 %
  • ROCE 9.61 %
  • ROE -419 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of -82.7% over last 3 years.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Sugar Industry: Sugar

Part of BSE 250 SmallCap Index Nifty 500 Multicap 50:25:25 Nifty 500 BSE 400 MidSmallCap Index BSE 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
1,966 1,984 1,920 2,130 2,484 2,045 2,214 2,487 2,875 3,298 2,891 2,440 2,428
1,805 1,736 1,868 2,069 2,293 1,808 2,137 2,418 2,663 3,085 2,812 2,201 2,448
Operating Profit 161 248 51 60 191 237 78 69 212 213 80 239 -20
OPM % 8% 12% 3% 3% 8% 12% 4% 3% 7% 6% 3% 10% -1%
15 29 20 23 17 48 74 13 13 14 26 18 36
Interest 86 95 119 120 131 171 193 195 222 218 190 188 174
Depreciation 47 50 56 57 58 58 62 62 64 64 65 66 66
Profit before tax 44 132 -103 -94 19 56 -104 -174 -61 -55 -149 3 -224
Tax % 0% -6% 0% 10% 0% 6% 1% 0% 161% 122% -9% -497% -13%
43 140 -103 -104 19 52 -104 -174 -159 -122 -135 20 -195
EPS in Rs 0.20 0.66 -0.49 -0.49 0.09 0.25 -0.49 -0.82 -0.75 -0.57 -0.64 0.10 -0.92
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
6,395 6,522 5,744 5,859 7,767 5,839 4,292 4,563 5,539 6,125 8,575 10,825 11,057
5,800 6,382 5,567 5,814 7,485 6,022 4,041 4,593 4,972 5,761 8,033 10,204 10,545
Operating Profit 595 140 177 45 282 -183 251 -29 567 364 542 621 512
OPM % 9% 2% 3% 1% 4% -3% 6% -1% 10% 6% 6% 6% 5%
7 -277 -131 21 51 -2,696 107 378 218 334 106 65 94
Interest 367 318 336 341 392 499 541 486 369 376 541 828 770
Depreciation 159 166 156 146 253 232 213 203 201 201 229 252 260
Profit before tax 76 -621 -446 -420 -312 -3,610 -396 -340 215 121 -123 -394 -424
Tax % 32% -25% -34% -34% -24% -17% -4% 62% 74% 7% 11% 42%
52 -466 -295 -278 -236 -2,982 -382 -551 56 113 -136 -560 -432
EPS in Rs 0.77 -6.94 -3.18 -2.99 -2.49 -15.56 -1.99 -2.88 0.26 0.53 -0.64 -2.63 -2.03
Dividend Payout % 65% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: 20%
3 Years: 25%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: -26%
3 Years: %
TTM: -12%
Stock Price CAGR
10 Years: 7%
5 Years: 37%
3 Years: -11%
1 Year: -39%
Return on Equity
10 Years: -27%
5 Years: -117%
3 Years: -83%
Last Year: -419%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 67 67 93 93 95 192 192 192 213 213 213 213 213
Reserves 1,726 1,269 1,445 3,140 2,261 700 355 -312 3 334 200 -359 -469
2,612 3,898 3,565 3,470 3,619 2,364 2,687 2,191 3,801 4,150 4,326 4,453 4,328
3,579 1,424 2,017 2,859 2,876 3,288 3,659 4,411 3,023 2,380 2,756 5,642 3,402
Total Liabilities 7,983 6,657 7,119 9,561 8,851 6,544 6,893 6,482 7,040 7,077 7,494 9,949 7,474
2,735 2,696 2,555 4,391 4,160 3,861 3,802 3,695 3,605 3,822 4,162 4,142 4,033
CWIP 27 24 27 29 33 27 100 152 9 239 115 59 111
Investments 2,013 2,014 1,947 1,949 1,961 126 109 104 138 120 119 445 445
3,208 1,923 2,590 3,192 2,698 2,530 2,882 2,531 3,288 2,895 3,099 5,302 2,886
Total Assets 7,983 6,657 7,119 9,561 8,851 6,544 6,893 6,482 7,040 7,077 7,494 9,949 7,474

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2,283 -565 261 489 193 -1,211 465 819 -1,532 206 857 1,114
-68 -17 58 -14 16 20 -325 -146 -158 -249 -345 -554
-2,133 536 -341 -478 -181 1,179 -154 -658 1,677 32 -453 -601
Net Cash Flow 81 -46 -21 -3 28 -12 -14 15 -13 -11 59 -41

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 10 14 18 24 28 44 15 12 19 18 9 18
Inventory Days 142 62 104 135 71 63 172 158 202 148 119 168
Days Payable 212 67 131 179 120 180 278 255 226 145 120 197
Cash Conversion Cycle -61 9 -9 -21 -22 -74 -91 -84 -5 20 8 -10
Working Capital Days -71 -23 -27 -36 -25 -88 -139 -196 -1 23 9 -11
ROCE % 9% 1% 0% -1% 1% -8% 7% -6% 14% 6% 9% 10%

Shareholding Pattern

Numbers in percentages

Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48% 62.48%
2.12% 2.66% 4.08% 4.19% 4.34% 2.93% 3.16% 3.22% 3.36% 3.43% 4.25% 3.28%
10.53% 9.68% 10.50% 10.44% 10.10% 10.10% 10.12% 10.10% 10.08% 10.08% 10.12% 10.13%
24.87% 25.18% 22.94% 22.88% 23.07% 24.49% 24.23% 24.20% 24.06% 23.98% 23.15% 24.09%
No. of Shareholders 3,71,7994,73,8954,57,2124,79,4955,00,8585,15,8236,03,7076,78,1537,14,8117,80,0118,01,6118,20,965

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Jun 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT